12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
Impel NeuroPharma, a late-stage developer of intranasal drug formulations for migraines and CNS diseases, raised $80 million by offering 5.3 million shares at $15, the midpoint of the range of $14 to $16. At pricing, the company commands a fully diluted market...read more
Impel NeuroPharma, a late stage biotech developing formulations of drugs for CNS diseases, announced terms for its IPO on Monday. The Seattle, WA-based company plans to raise $80 million by offering 5.3 million shares at a price range of $14 to $16. At the...read more
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more
US IPO Weekly Recap: UiPath’s billion-dollar deal leads a 12 IPO Week
12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
CNS therapy developer Impel NeuroPharma prices IPO at $15 midpoint
Impel NeuroPharma, a late-stage developer of intranasal drug formulations for migraines and CNS diseases, raised $80 million by offering 5.3 million shares at $15, the midpoint of the range of $14 to $16. At pricing, the company commands a fully diluted market...read more
CNS therapy developer Impel NeuroPharma sets terms for $80 million IPO
Impel NeuroPharma, a late stage biotech developing formulations of drugs for CNS diseases, announced terms for its IPO on Monday. The Seattle, WA-based company plans to raise $80 million by offering 5.3 million shares at a price range of $14 to $16. At the...read more
US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more